ABIVAX Société Anonyme ABVX
Set alert
86.59 USD -2.47 -2.77%
At close · Oct 30
87.03 +0.44 +0.51%
After hours · Oct 30, 7:30 PM ET
85.81 Day range 88.90
72.50 52-week range 145.31
- YTD
- -35.79%
- 1 year
- -16.97%
- Open
- 87.66
- Prev close
- 89.06
- Mkt cap
- 7.58B
- Vol
- 843.41K
- Avg vol
- 1.10M
- EPS
- -6.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 85.81
- High
- 88.90
- Forward P/E
- -22.58
- Beta
- -0.23
- Short ratio
- 5.08
- Inst. own
- 72.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 21, 2026
- 50-d avg
- 100.77
- 200-d avg
- 114.29
- 1y target
- 163.58
MAX chart
Events in this range
- Sep 8, 2025Earnings: -0.86; estimate -0.9; surprise 4.44%
- Dec 15, 2025Earnings: -2.4717; estimate -0.78649; surprise -214.27%
- Mar 23, 2026Earnings: -1.19; estimate -1.7; surprise 30%
- May 22, 2026Earnings: -0.71; estimate -1.07; surprise 33.64%
- Sep 10, 2026Rating: Goldman Sachs · — → Buy
- Sep 21, 2026Earnings: -1.71; estimate -0.97553; surprise -75.29%
- Sep 22, 2026Rating: Barclays · Overweight → Overweight
- Sep 22, 2026Rating: Wedbush · Neutral → Neutral
- Sep 22, 2026Rating: Truist Securities · Buy → Buy
- Oct 20, 2026Rating: Guggenheim · Buy → Buy
- Oct 21, 2026Rating: Wedbush · Neutral → Neutral
Signals (47)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | Jun 29, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Jan 5, 2026 | 10 months ago |
| RSI: Overbought | Jul 21, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 16, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 12, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 17, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| RSI: Oversold | Jan 6, 2025 | 1 year ago |
| RSI: Oversold | Dec 9, 2024 | 1 year ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| SMA: Bearish | Jul 15, 2024 | 2 years ago |
| SMA: Bullish | Jul 8, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Apr 29, 2024 | 2 years ago |
Financial health
Altman Z-Score
37.98 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -24.7×
FY 2016 5y median -2.7× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 17.5×
FY 2016 5y median 11.0× FY 2025
P/FCF -51.2×
FY 2016 5y median -2.9× FY 2025
EV/EBITDA -25.0×
FY 2016 5y median -2.7× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -2.0%
FY 2016 5y median -34.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -73.9%
FY 2016 5y median -163.7% FY 2025
ROIC -44.7%
FY 2016 5y median -47.1% FY 2025
ROA -57.5%
FY 2016 5y median -57.5% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -42.2%
FY 2016 FY 2025
EPS (diluted) -66.1%
FY 2016 FY 2025
Free Cash Flow -0.7%
FY 2016 FY 2025
Financial Health
Current Ratio 8.7×
FY 2016 5y median 2.3× FY 2025
Quick Ratio 8.7×
FY 2016 5y median 2.2× FY 2025
Debt / Equity 0.1×
FY 2016 5y median 2.0× FY 2025
Net Debt / EBITDA 1.6×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -8.6×
FY 2016 5y median -9.3× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31